The Role of mTOR Inhibitors in COVID-19 Outcomes Among Heart Transplant Recipients
mTOR-based immunosuppression was non-inferior to standard therapy for COVID-19 outcomes. The absence of COVID-19-related deaths in patients on mTOR CNI-free regimens suggests potential protective effects that merit further investigation.
Authors
- Piotr Przybyłowski (ORCID: https://orcid.org/0000-0002-8114-3219)
- Szymon Pawlak (ORCID: https://orcid.org/0000-0001-9347-9839)
- Szymon Warwas (ORCID: https://orcid.org/0000-0001-9930-5864)
- Agnieszka Kuczaj (ORCID: https://orcid.org/0000-0002-9462-0467)
- Tomasz Hrapkowicz (ORCID: https://orcid.org/0000-0002-8945-7351)
- Oliwia Jewuła
- Błażej Skotnicki
- Daniel Szymecki
- Mikołaj Tyrka
Institutions
- Medical University of Silesia (PL)
- Silesian Center for Heart Disease (PL)
Publication Details
- Journal
- Viruses
- Published
- 2025-12-24
- DOI
- https://doi.org/10.3390/v18010029
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Uniwersytet Śląski w Katowicach